Logo: to the web site of Uppsala University

Phase III trial of gemcitabine plus carboplatin versus single-agent gemcitabine in the treatment of locally advanced or metastatic non-small-cell lung cancer: the Swedish Lung Cancer Study Group. 2005 (English)In: J Clin Oncol, ISSN 0732-183X, Vol. 23, no 33, p. 8380-8Article in journal (Refereed) Published

Place, publisher, year, edition, pages

2005. Vol. 23, no 33, p. 8380-8

Keywords [en]

Adult, Age Factors, Aged, Aged; 80 and over, Antineoplastic Combined Chemotherapy Protocols/adverse effects/*therapeutic use, Carboplatin/administration & dosage/adverse effects, Carcinoma; Non-Small-Cell Lung/*drug therapy/mortality/pathology, Comparative Study, Deoxycytidine/administration & dosage/adverse effects/analogs & derivatives, Disease-Free Survival, Female, Humans, Lung Neoplasms/*drug therapy/mortality/pathology, Male, Middle Aged, Proportional Hazards Models, Quality of Life, Research Support; Non-U.S. Gov't, Statistics; Nonparametric, Survival Analysis, Sweden/epidemiology

Identifiers

URN: urn:nbn:se:uu:diva-80495PubMedID: 16293868OAI: oai:DiVA.org:uu-80495DiVA, id: diva2:108409

Available from: 2006-05-22 Created: 2006-05-22 Last updated: 2011-01-11

Open Access in DiVA

No full text in DiVA

Other links

PubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=16293868&dopt=Citation

By organisation

Department of Medical Sciences

Search outside of DiVA

GoogleGoogle ScholarTotal: 496 hits